Psychedelic drugs, psilocybin, and transcendent experiences as antidepressants | Charles Raison

Posted on August 27th 2019 (over 5 years)

The BDNF Protocol Guide

An essential checklist for cognitive longevity — filled with specific exercise, heat stress, and omega-3 protocols for boosting BDNF. Enter your email, and we'll deliver it straight to your inbox.

Your subscription could not be saved. Please try again.
Please check your email to confirm your subscription and get The BDNF Protocol Guide!

You'll also receive updates from Rhonda & FoundMyFitness

The mammalian brain seems drawn to substances that induce altered states of consciousness. For example, cats crave catnip, elks seek out a hallucinogenic moss, and humans around the world have used psychedelic substances. Researchers studying the psychedelic compound psilocybin and its potential effects on depression observed that a single exposure in humans induced a powerful anti-depressive response that persisted for six months or longer. Investigators speculate that the anti-depressive effect may result from the subjects having a mystical experience rather than the psychedelic agent itself. Dampening of the default mode network in the brain may also play a role in the anti-depressive effect. The default mode network is involved in rumination, a significant component of depression that some studies have linked to inflammation. In this clip, Dr. Charles Raison discusses how psychedelic substances like psilocybin, which induce transcendent trance-like states, may be useful in the treatment of depression.

Attend Monthly Q&As with Rhonda

Support our work

The FoundMyFitness Q&A happens monthly for premium members. Attend live or listen in our exclusive member-only podcast The Aliquot.

Become a premium member and get access to all our member benefits starting at $15/mo. Sign up for an annual subscription and receive an additional 15% discount.

Depression Videos